Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Raboud

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Predicting HIV RNA virologic outcome at 52-weeks follow-up in antiretroviral clinical trials. The INCAS and AVANTI Study GroupsJ M Raboud, S Rae, J S Montaner
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1995
Variability in leukocyte subset measurements among five laboratories in VancouverK Mandigo, J M Raboud, L Haley, et al.
Journal of Clinical Pathology|January 1, 1995
Effect of thromboplastin and coagulometer interaction on the precision of the International Normalised RatioD W Pi, J M Raboud, C Filby, et al.
HIV Medicine|May 16, 2002
Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapyJ M Raboud, M Harris, S Rae, et al.
Journal of Clinical Microbiology|November 4, 2000
Can pooling be used for seroprevalence studies of hepatitis C?G M Stephens, J M Raboud, L Karakas, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1996
Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. Canadian HIV Trials Network A002 Study GroupJ M Raboud, J S Montaner, A Thorne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 16, 1998
Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and deathJ M Raboud, J Singer, A Thorne, et al.
Journal of Clinical Microbiology|September 1, 1993
Combining pooling and alternative algorithms in seroprevalence studiesJ M Raboud, C Sherlock, M T Schechter, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation studyJ M Raboud, M C Boily, J Rajeswaran, et al.
The Journal of Infectious Diseases|March 1, 1997
Issues in the design of trials of therapies for subjects with human immunodeficiency virus infection that use plasma RNA level as an outcomeJ M Raboud, J S Montaner, S Rae, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Predicting HIV RNA virologic outcome at 52-weeks follow-up in antiretroviral clinical trials. The INCAS and AVANTI Study GroupsJ M Raboud, S Rae, J S Montaner
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1995
Variability in leukocyte subset measurements among five laboratories in VancouverK Mandigo, J M Raboud, L Haley, et al.
Journal of Clinical Pathology|January 1, 1995
Effect of thromboplastin and coagulometer interaction on the precision of the International Normalised RatioD W Pi, J M Raboud, C Filby, et al.
HIV Medicine|May 16, 2002
Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapyJ M Raboud, M Harris, S Rae, et al.
Journal of Clinical Microbiology|November 4, 2000
Can pooling be used for seroprevalence studies of hepatitis C?G M Stephens, J M Raboud, L Karakas, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1996
Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. Canadian HIV Trials Network A002 Study GroupJ M Raboud, J S Montaner, A Thorne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 16, 1998
Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and deathJ M Raboud, J Singer, A Thorne, et al.
Journal of Clinical Microbiology|September 1, 1993
Combining pooling and alternative algorithms in seroprevalence studiesJ M Raboud, C Sherlock, M T Schechter, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation studyJ M Raboud, M C Boily, J Rajeswaran, et al.
The Journal of Infectious Diseases|March 1, 1997
Issues in the design of trials of therapies for subjects with human immunodeficiency virus infection that use plasma RNA level as an outcomeJ M Raboud, J S Montaner, S Rae, et al.
Pageof 4